Insider · CIK 0001827711

Pestano Gary Anthony

Reports to the SEC for 1 company · LOUISVILLE, CO

sec.gov

Transactions

Companies

Filings

CIK

0001827711

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-23	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−556 sh	$12.78	−$7,103.234	10,359
2026-02-20	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,528 sh	—	—	4,582
2026-02-20	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,528 sh	—	—	10,915
2026-02-10	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−540 sh	$10.08	−$5,445.414	9,387
2026-02-09	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−68 sh	—	—	0
2026-02-09	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,413 sh	—	—	1,412
2026-02-09	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,481 sh	—	—	9,927
2026-01-16	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−298 sh	$8.15	−$2,428.491	8,446
2026-01-15	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+805 sh	—	—	8,744
2026-01-15	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−805 sh	—	—	1,609
2026-01-02	BDSXBIODESIX INC · Stock Options (Right to Buy)A Award	Chief Development Officer	AAward	+26K sh	—	—	26,000
2025-11-10	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+69 sh	—	—	7,962
2025-11-10	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−23 sh	$7.62	−$175.26	7,939
2025-11-10	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−69 sh	—	—	68
2025-08-13	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−442 sh	$0.42	−$184.005	157,878
2025-08-12	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,379 sh	—	—	158,320
2025-08-12	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,379 sh	—	—	2,756
2025-05-13	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−222 sh	$0.35	−$78.344	156,941
2025-05-12	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−223 sh	$0.36	−$80.146	157,163
2025-05-09	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,378 sh	—	—	4,135
2025-05-09	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,378 sh	—	—	157,386
2025-02-20	BDSXBIODESIX INC · Stock Options (Right to buy)A Award	Chief Development Officer	AAward	+244K sh	—	—	244,400
2025-02-20	BDSXBIODESIX INC · Stock Options (Right to buy)A Award	Chief Development Officer	AAward	+3,810 sh	—	—	3,810
2025-02-20	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Chief Development Officer	AAward	+122K sh	—	—	122,200
2025-02-11	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−16.7K sh	$0.92	−$15.5K	156,008
2025-02-10	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−16.1K sh	—	—	48,286
2025-02-10	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−28.3K sh	—	—	56,510
2025-02-10	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+45.7K sh	—	—	172,756
2025-02-10	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,378 sh	—	—	5,513
2024-11-12	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−207 sh	$1.40	−$289.966	127,027
2024-11-11	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−220 sh	$1.39	−$305.998	127,234
2024-11-08	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,378 sh	—	—	127,454
2024-11-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,378 sh	—	—	6,891
2024-08-12	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−111 sh	$1.57	−$174.481	126,076
2024-08-09	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−320 sh	$1.60	−$512.32	126,187
2024-08-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,379 sh	—	—	8,269
2024-08-08	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,379 sh	—	—	126,507
2024-05-23	BDSXBIODESIX INC · Series A Non-Voting Convertible Preferred StockM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−22 sh	—	—	0
2024-05-23	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+880 sh	—	—	125,128
2024-05-09	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−434 sh	$1.48	−$642.103	124,248
2024-05-08	BDSXBIODESIX INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,378 sh	—	—	124,682
2024-05-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,378 sh	—	—	9,648
2024-04-05	BDSXBIODESIX INC · Series A Non-Voting Convertible Preferred StockA Award	Chief Development Officer	AAward	+22 sh	$46.00	+$1,012	22
2024-02-21	BDSXBIODESIX INC · Stock Options (Right to buy)A Award	Chief Development Officer	AAward	+3,690 sh	—	—	3,690
2024-02-12	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−5,022 sh	$1.66	−$8,360.123	123,250
2024-02-09	BDSXBIODESIX INCS Sale	Chief Development Officer	SSale	−5,862 sh	$1.92	−$11.2K	128,272
2024-02-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−28.3K sh	—	—	84,766
2024-02-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,378 sh	—	—	11,026
2024-02-08	BDSXBIODESIX INC · Stock Options (Right to buy)A Award	Chief Development Officer	AAward	+129K sh	—	—	128,761
2024-02-08	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Chief Development Officer	AAward	+64.4K sh	—	—	64,381

Recent filings

Accepted (ET)
Feb 234
Pestano Gary Anthony0000905148-26-000987
SEC(opens sec.gov)
Feb 114
Pestano Gary Anthony0000905148-26-000634
SEC(opens sec.gov)
Jan 204
Pestano Gary Anthony0000905148-26-000252
SEC(opens sec.gov)
Jan 64
Pestano Gary Anthony0000905148-26-000068
SEC(opens sec.gov)
Nov 134
Pestano Gary Anthony0000905148-25-003932
SEC(opens sec.gov)
Aug 144
Pestano Gary Anthony0000905148-25-002981
SEC(opens sec.gov)
May 134
Pestano Gary Anthony0000905148-25-001608
SEC(opens sec.gov)

Companies

BIODESIX INCChief Development OfficerBDSX

Address

919 WEST DILLON RD

LOUISVILLE, CO, 80027